Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001415889-25-018509
Filing Date
2025-06-30
Accepted
2025-06-30 16:15:15
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 27630
2 JOINT FILING AGREEMENT ex-99-06302025_080613.htm EX-99.1 8087
  Complete submission text file 0001415889-25-018509.txt   37401
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Subject) CIK: 0000316253 (see all company filings)

EIN.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: SCHEDULE 13D | Act: 34 | File No.: 005-32878 | Film No.: 251092207
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address ONE MARINA PARK DRIVE, SUITE 1100 BOSTON MA 02210
Business Address ONE MARINA PARK DRIVE, SUITE 1100 BOSTON MA 02210 617-948-3600
Battery Ventures XIV, L.P. (Filed by) CIK: 0001912746 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D